[Anti-infective treatment in obesity-"just double it?"]

Anaesthesist. 2020 Aug;69(8):588-592. doi: 10.1007/s00101-020-00800-y.
[Article in German]


Adaequate antibiotic therapy is crucial for successful anti-infective therapy. In addition to the choice of the right antibiotic and the duration of therapy, the dose also plays a decisive role. Obesity has an influence on the pharmacokinetics of antibiotics, which can lead to underdosing if previous weight-independent dosing regimes are used. It is therefore necessary to carry out systematic measurements of concentrations in obese patients. Since pharmacokinetic differences between plasma and the interstitial fluid of different target tissues have been observed for different antibiotics, the measurement is also necessary in the target tissue. The technique of microdialysis is best suited for this purpose as it allows concentrations to be measured continuously in the target tissue.

Keywords: Antibiotics; Dosing; Microdialysis; Pharmacokinetics; Target tissue.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / administration & dosage*
  • Anti-Infective Agents / therapeutic use*
  • Humans
  • Microdialysis
  • Obesity*


  • Anti-Bacterial Agents
  • Anti-Infective Agents